Analyze mutual fund ownership, AMC exposure and portfolio concentration for GLAXOSMITHKLINE PHARMA LTD.
GLAXOSMITHKLINE PHARMA LTD is currently held by 4 mutual funds with a combined exposure of 3.65% .
The top 10 mutual funds together account for approximately 3.65% portfolio weight in this company.
This stock is most actively owned by 1 AMCs across multiple mutual fund categories.